Table 3.

Distribution of types of event and of survival status of children with T-lymphoblastic lymphoma according to genetic subgroups



Total population studied, n (%)

Subgroup

All HOX11L2-negative, n (%)

HOX11L2-positive, n (%)
HOX11-high, n (%)
SIL-TAL, n (%)
Other, n (%)*
Total, N (%)   11 (100)   1 (100)   1 (100)   2 (100)   7 (100)   11 (100)  
Type of event       
    No event (ie, in CCR)   10 (90.9)   1 (100)   1 (100)   1 (100)   6 (85.7)   10 (90.9)  
    BM only   1 (9.1)   0 (0)   0 (0)   0 (0)   1 (14.3)   1 (9.1)  
Survival status       
    Alive   10 (90.9)   1 (100)   1 (100)   1 (100)   6 (85.7)   10 (90.9)  
    Dead
 
1 (9.1)
 
0 (0)
 
0 (0)
 
0 (0)
 
1 (14.3)
 
1 (9.1)
 


Total population studied, n (%)

Subgroup

All HOX11L2-negative, n (%)

HOX11L2-positive, n (%)
HOX11-high, n (%)
SIL-TAL, n (%)
Other, n (%)*
Total, N (%)   11 (100)   1 (100)   1 (100)   2 (100)   7 (100)   11 (100)  
Type of event       
    No event (ie, in CCR)   10 (90.9)   1 (100)   1 (100)   1 (100)   6 (85.7)   10 (90.9)  
    BM only   1 (9.1)   0 (0)   0 (0)   0 (0)   1 (14.3)   1 (9.1)  
Survival status       
    Alive   10 (90.9)   1 (100)   1 (100)   1 (100)   6 (85.7)   10 (90.9)  
    Dead
 
1 (9.1)
 
0 (0)
 
0 (0)
 
0 (0)
 
1 (14.3)
 
1 (9.1)
 
*

Negative for 3 genetic markers.

This group included 11 patients: 1 patient with HOX11-high, 2 patients positive for SIL-TAL, 7 patients with other, and 1 additional patient negative for HOX11L2 but with unknown HOX11 and SIL-TAL status.

or Create an Account

Close Modal
Close Modal